Isolation and Immunological Detection of Mycobacterium Tuberculosis from HIV and Non-HIV Patients in Benue State, Nigeria by Francis Enenche Ejeh1 et al.
              
           Isolation and Immunological Detection…                                              Ejeh E. F  et al.                                                                                           
 
 





Isolation and Immunological Detection of Mycobacterium Tuberculosis 
from HIV and Non-HIV Patients in Benue State, Nigeria 
 
Francis Enenche Ejeh1,4*, Ann Undiandeye2, Kenneth Okon3, Haruna Moshud 
Kazeem4, Ayuba Caleb Kudi5 
 
 
OPEN ACCESS  
 
Citation: Francis Enenche Ejeh, Ann 
Undiandeye, Kenneth Okon, Haruna 
Moshud Kazeem, Ayuba Caleb Kudi. 
Isolation and Immunological Detection of 
Mycobacterium Tuberculosis from HIV 
and Non-HIV Patients in Benue State, 
Nigeria. Ethiop J Health 
Sci.2020;30(1):55.doi:http:// dx.doi.org/ 
10.4314/ejhs.v30i1.8  
Received: June 26, 2019  
Accepted: September 02, 2019 
Published: January 1, 2020 
Copyright: © 2020 Ejeh E. F, et al. This 
is an open access article distributed under 
the terms of the Creative Commons 
Attribution License, which permits 
unrestricted use, distribution, and 
reproduction in any medium, provided the 
original author and source are credited.  
Funding: Nil 
Competing Interests: The authors declare 
that this manuscript was approved by all 
authors in its form and that no competing 
interest exists.  
Affiliation and Correspondence: 
1Department of Veterinary 
Microbiology, University of 
Maiduguri, Borno, Nigeria 
2Federal Medical Center, Yola, 
Adamawa State, Nigeria 
3Department of Medical 
Microbiology, Federal Medical 
Center, Makurdi, Benue State, Nigeria 
4Department of Veterinary 
Microbiology, ABU, Zaria 













BACKGROUND: Immunological techniques are important tools for 
tuberculosis epidemiology; although its use is underutilized in 
Nigeria. In this study, we report the epidemiological outlook of 
Mycobacterium tuberculosis among HIV patients in Benue State, 
Nigeria.  
METHODS: Sputum samples were collected from 425 suspected TB 
patients from July 2016 to February 2018 and subjected to acid-fast 
microscopy, GeneXpert MTB/RIF, processed using NALC-NaOH 
and cultured on Lowenstein-Jensen media. The isolates obtained 
were identified by SD-Bioline® assay.  
RESULTS: The prevalence of TB by acid-fast microscopy was 
35(15.9%). The prevalence of TB by acid-fast bacilli was 
significantly (χ2 = 8.458; P = 0.003) highest among the 15-34 years 
age group (22.0%) compared with other age groups. TB prevalence 
was significantly (χ2 = 4.751; P = 0.029) higher among patients from 
rural areas than those from urban center (23.8% vs 14.1%). 
GeneXpert assay detected 64(15.1%) TB cases of which patients 
from rural areas had significantly (χ2 = 8.104; P = 0.017) higher 
prevalence of TB than patients from urban areas (23.8% vs 12.9%). 
The overall rifampicin resistance TB was 3.1%. Also, patients from 
rural areas had significantly (χ2 = 10.625; P = 0.005) higher 
rifampicin resistance compared with patient from urban areas (8.3% 
vs 1.3%). Of the 126(29.7%) mycobacterial isolates, 42(33.33%) 
were identified as MTBC and 84 (66.67%) as NTM by SD-Bioline® 
assay.  
CONCLUSIONS: The study revealed that Mycobacterium 
tuberculosis infection is still a major public health problem, with 
relatively high prevalence rate of rifampicin resistance among HIV 
positive patients. Further studies are needed for early detection and 
treatment intervention necessary for infection control. 
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Tuberculosis (TB) caused by Mycobacterium 
tuberculosis is both a preventable and treatable 
disease but it is the leading cause of death globally 
(1). The organism is responsible for over 9 million 
TB cases and 1.7 million deaths annually (2). TB 
and Human immunodeficiency Virus (HIV) 
coinfection and the emergency of drug resistance 
TB are the drivers for the reemergence of TB in 
Nigeria (3). 
Globally, Nigeria ranks among the 22 high TB 
burdened countries and the second in Africa (4). 
Benue State in Nigeria has high TB prevalence 
which is worsened due to high rate of HIV/AIDS 
and poverty (5). There exists strong relationship 
between TB and HIV/AIDS. For example, an HIV 
infected individual has high risk of rapid disease 
progression. Similarly, there is high rate of TB 
treatment failure among HIV infected patient than 
HIV negative TB patients. Also, TB patients with 
HIV infection demonstrate greater mortality as high 
as 20-30% in resource limited settings like Nigeria 
(6–8). 
There have been serval reports of the 
prevalence of TB in different parts of Nigeria. A 
prevalence of 10.5% was reported among HIV 
positive patients in Kano State (9). Ojiezeh et al., 
(10) reported a prevalence of 14.0% among HIV 
individuals in Owo, Southwest Nigeria. Other 
studies include: 6.1% in Jos (11); 12.7% in Ife (12); 
14.7% in another study in Kano (13); 19.0% in 
Maiduguri (14); 21.5% in Benue State (15) and 
28.1% in Ibadan (16). These studies were mostly 
based on retrospective data which has inherent 
problems such as poor record keeping and several 
human limitations. Also, the lack of isolation and 
identification of Mycobacterium tuberculosis in 
earlier studies in Benue State may account for the 
under reporting of the impact of the disease in Benue 
State (17,18). The aim of this study was to determine 
the prevalence of tuberculosis and rifampicin 
resistance among HIV and non-HIV patients in 
Benue State. 
 
MATERIALS AND METHODS 
 
Study areas: Benue State lies between latitudes 
6°25'N and 8°8'N and longitudes 7°47'E and 10°E' 
(Figure 1). It is surrounded by five States, namely 
Nassarawa to the north, Taraba to the northeast, 
Cross River to the south, Anambra to the southwest 
and Kogi to the west. There is also a short 
international boundary between the State and the 
Republic of Cameroun along Nigeria's southern 
border. The State has a population of over 4 million 
people (19). 
The climatic condition of Benue State is 
influenced by two air masses: the warm, moist south 
westerly air mass and the dry northeasterly air mass. 
The rainy season begins in the month of May and 
ends in October (19). Benue State is known as the 
food basket of the nation because of its high 
agricultural activity and level of food production.  
Makurdi, Gwer East and Otukpo Local 
government areas represent the major local 
governments in two of the three senatorial zones in 
Benue State where tuberculosis referral centres are 
located. Also, Federal Medical Centre (FMC), 
Makurdi; General Hospital, North Bank; St. Vincent 
Hospital, Aliade and General Hospital, Otukpo are 
the main hospitals for tuberculosis diagnosis and 
treatment in Benue State which are designated as 
tuberculosis referral centers. 
 
 
Figure 1: Map of Benue state showing the study 
area  
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Study design: A case-control study based on 
tuberculosis cases was carried out in Directly 
Observed Treatment (DOT) centers and hospitals in 
Makurdi, Otukpo and Gwer East to evaluate the 
prevalence of tuberculosis due to Mycobacterium 
tuberculosis complex among HIV and non-HIV 
patients in Benue State, Nigeria. 
Ethical approval: The permission 
(BSUTH/MKD/HREC2013B/2017/0011) to 
conduct this study was obtained from the Health 
Research Ethics Committee, Benue State University 
Teaching Hospital, Makurdi, and the Research and 
Ethics Committee of the Federal Medical Centre of 
Makurdi (FMC/MED108/VOL1/X), Nigeria. There 
is no way to trace patients’ identities from the results 
generated in this study. 
Inclusion Criteria 
Location: The locations of this study were Makurdi 
general hospital, Federal Medical Center, Apir, St. 
Vincent Hospital, Aliade, Gwer East and General 
hospital Otukpo. 
Conditions: The wiliness to participate in the study, 
suspected tuberculosis patients that are attending 
tuberculosis clinic and was tested for HIV infection. 
Collection of sputum samples from suspected 
human TB Patients: Regular visits were made to 
tuberculosis and chest hospitals and clinics in Benue 
State from July 2016 to February 2017. The 
hospitals include: General Hospital, Otukpo; St. 
Vincent Hospital, Aliade; Federal Medical Centre, 
Makurdi and General Hospital North Bank, 
Makurdi. Sputum from suspected TB/HIV co-
infected individuals and TB patients who were 
willing to participate in the study were collected on 
daily basis until the end of February 2017. 
A total of 425 sputum samples were collected 
from suspected TB patients in Benue State. Three 
hundred and fifty-two samples were collected from 
suspected patient in Federal Medical Center 
Makurdi and General hospital, North Bank, 59 
sputum samples from Otukpo General Hospital and 
17 sputum samples from suspected TB patients from 
St. Vincent Hospital, Aliade.  Suspected sputa were 
collected in a sterile sample container and stored at 
-20°C in the medical laboratory of the Federal 
Medical Centre Makurdi and the General Hospital 
Otukpo for a period of one to two weeks before 
transportation to the tuberculosis laboratory, 
University of Ibadan for bacteriological culture and 
identification. 
 
Mycobacteria culture of specimens from sputum 
samples: Processing and culture of sputum samples 
were done as described by GLI (2014). This 
includes digestion and decontamination of samples 
with NALC-(N-acetyl-L-cysteine)-NaOH. It was 
then followed by inoculation on paired Lowenstein 
Jensen media with glycerol and pyruvate and 
incubated at 37°C for between 8 and 12 weeks. 
Routine precautions were taken to avoid laboratory 
cross-contamination. Three sub-cultures of each 
positive culture were made and stored at -20°C for 
further use. 
Immunological Identification of Mycobacterium 
tuberculosis complex: Immunological 
identification of isolates was done by rapid detection 
of MPT64 protein. The 28kDa (MPT64) early 
secretory protein had been identified as one of the 
candidates for immunological diagnosis of TB. The 
protein is encoded by RD2, a genomic region of 
difference that is deleted in all M. bovis BCG but 
conserved among other members of the MTBC 
(20,21). An immunochromatographic assay, SD 
BIOLINE TB Ag MPT64 RAPID® (SD Bioline 
assay) which is based on the MPT64 protein was 
used to differentiate M. tuberculosis from non-
tuberculous mycobacteria. 
The SD bioline assay was performed on acid-
fast bacilli in 7H9 broth, as described by the 
manufacturer. Liquid culture (0.1 ml) was put onto 
the sample well. The test cassettes strips were 
incubated for 15-30 minutes at room temperature. 
The pink band in the ‘C’ region confirmed the test 
validity. An additional pink band in the ‘T’ region 
was interpreted as positive for the MPT64 Ag. Only 
the pink band in the ‘C’ region and no band in the 
‘T’ region were considered negative for the MPT 64 
antigen. No band in ‘C’ region was interpreted as an 
invalid test (22–25). 
Statistical analysis: Data were cross tabulated, Chi-
square was used to compare differences in TB 
detection rate among demographic variable using 
SPSS version 17. Results obtained were considered 
significant at a level of P value < 0.05. 
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Demographic characteristics of study 
participants: During July 2016 to February 2017 
total of 425 suspected TB patients participated in the 
study. Of the 425 participants, 220(51.8%) were 
males. One hundred and fifty-nine (37.4%) and 
163(38.4%) were in the age group of 15 – 34 and 35-
54 years.  One hundred and fifty-nine (37.4%) and 
243(57.2%) were HIV positive and HIV negative. 
Two hundred and ninty-seven (69.9%) do no 
consume local milk products. Three hundred and 
forty-one (80.2%) lived in the urban areas. Two 
hundred and sixty seven (62.8%) were Tiv and 119 
(28.0%) were Idoma. Three hundred and thirty-four 
(78.6%) attended FMC, Makurdi and 59(13.9%) 
attended General hospital, Otukpo (Table 1). 
 
Table 1: Demographic Characteristics of Human 
Study Participants 
Characteristics Frequency (%),  




Age group  
0 – 14 24(5.7) 
15 – 34 159(37.4) 
35 – 54 163(38.4) 
≥ 55 79(18.6) 


















St. VH 17(4.0) 
Total  425(100.0) 
FMC = Federal Medical Centre; GHOTKP = General Hospital 
Otukpo; GHNB = General Hospital, North Bank; St. VH = Saint 
Vincent Hospital 
Prevalence of tuberculosis in Benue State based 
on AFB test: A total of 425 suspected TB patients 
were screened for tuberculosis using AFB test. The 
overall prevalence of tuberculosis by AFB was 
16.0%. Prevalence of TB between sex by AFB test 
was not significantly (χ2 = 0.003, P = 0.958) 
different-(35 (15.9%) males vs 33 (16.1%) females). 
Prevalence of TB among the age group of 15-34 
years (22.0%) was significantly (χ2 = 8.458, P = 
0.037) higher than other age groups. HIV positive 
patients had higher prevalence of TB than those who 
were HIV negative (19.5% vs 15.4%). However, the 
difference was not statistically significant (χ2 = 
5.594, P = 0.061). Also, the prevalence of TB among 
those who consume local milk products and those 
who do not consume local milk product was not 
significantly (χ2 = 0.526, p = 0.467) different. 
Prevalence of TB was significantly (χ2 = 4.751, P = 
0.029) higher among rural dwellers, 20(23.8%), than 
those from urban areas, 48(14.1%). Prevalence of 
TB diagnosed at General Hospital, Otukpo, was 
higher (χ2 = 20.122, P = 0.000) than other hospitals 
in this study areas (Table 2). 
Prevalence of TB in Benue State using 
GeneXpert assay: Results from GeneXpert assay 
for the 425 participants in this study showed an 
overall prevalence of 15.1%, of which 37(16.8%) 
males and 27 (13.2%) females were positive to TB. 
Prevalence of TB among all age groups was not 
significantly (χ2 = 2.003, p = 0.919) different. 
Although the prevalence (11.4%) was lowest among 
people who are greater or equal to 55 years of age 
and highest among 15-34 age group. Prevalence of 
TB by GeneXpert assay was highest among HIV 
patient than non-HIV patients (18.2% vs 14.3%). 
There was no positive TB case among patients with 
unknown HIV status. Patients who consume local 
milk products had higher prevalence than those who 
do not (18.0% vs 13.8%). However, the difference 
was not significant (χ2 = 1.831, P = 0.400) 
statistically. The prevalence of TB using GeneXpert 
by location varies significantly (χ2 = 8.104, P = 
0.017); patients from rural areas had 20 (23.8%) and 
patients from urban areas had 40 (12.9%). Also, the 
prevalence of TB among the different ethnic groups 
was significantly (χ2 = 29.758, p = 0.000) different. 
The Idoma ethnic group had 25(27.7%) compared 
with Tiv 33 (9.4%)
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Table 2: Prevalence of tuberculosis in Benue State based on Acid-Fast Bacilli Test. 
 
 
Variables No. Sampled AFB Test (%) 𝜒2 P value 
Sex     
Male 220 35(15.9) 0.003 0.958 
Female 205 33(16.1)   
Age group     
0 – 14 24 1(4.2) 8.458 0.037 
15 – 34 159 35(22.0)   
35 – 54 163 23(14.1)   
≥ 55 79 9(11.4)   
HIV Status     
HIV Positive 159 31(19.5) 5.594 0.061 
HIV Negative 243 37(15.4)   
Unknown 21 0(0.0)   
Consumption of nono     
Yes 128 23(18.0)   
No 297 45(15.2) 0.528 0.467 
Location     
Urban 341 48(14.1) 4.751 0.029 
Rural 84 20(23.8)   
Ethnicity     
Tiv 267 37(13.9) 3.144 0.208 
Idoma 119 25(21.0)   
others 39 6(15.4)   
Hospital      
FMC 334 42(12.6) 20.122 0.000 
GHOTKP 59 19(32.2)   
GHNB 15 1(6.7)   
St. VH 17 6(35.3)   
Total  425 68(16.0)   
 
and other 6(15.4) ethnic groups. Patients diagnosed 
at General Hospital, Otukpo, and St. Vincent 
Hospital, Aliade, had higher prevalence of TB 
(49.2% and 41.2%) compared with patients from 
Federal Medical Centre, Makurdi (8.4%). 
GeneXpert assay was not available at the General 
Hospital, Northbank, at the time of this study (Table 
3). 
Isolation and identification of Mycobacterium 
tuberculosis complex from TB patient in Benue 
State: The overall isolation rate of MTBC and NTM 
was 42(33.3%) and 84(66.7%) respectively. 
Mycobacterium isolation on LJ media was 
significantly (χ2 = 3.879, P = 0.049) higher among 
males, 68(30.9%) than among females 46(22.1%) 
patients. Identification by Immunological 
identification of MP64 protein (SD-Bioline assay) 
showed that MTBC isolation was higher among 
male than female TB patients. The difference was 
not statistically significant (χ2 = 5.609, P = 0.061). 
HIV negative patients and those whose HIV status 
was unknown had higher isolation rates of 
Mycobacterium (26.4% and 27.8%). Identification 
of MTBC was highest among HIV positive patients; 
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patients whose HIV status was unknown were 
negative for MTBC. Other ethnic group had the 
highest mycobacteria isolation rate; it also had the 
lowest rate of MTBC. Tiv and Idoma ethnic groups 
had the highest rate of MTBC respectively. The 
isolation rate of MTBC among ethnic groups was 
significantly (χ2 = 53.192, P = 0.000) different. Of 
the 6(40%) mycobacteria isolated from patients who 
attended General Hospital, Northbank, 0(0.0%), was 
identified as MTBC. Samples from the Federal 
Medical Centre, Makurdi, had the highest rate 
(6.4%) of MTBC identification. Identification of 
MTBC varies significantly (χ2 = 156.000, P = 
0.000) among the hospitals in this study (Table 3).  
 
Table 3: Prevalence of TB in Benue State using GeneXpert assay 
 
Variables No. Sampled GeneXpert Assay (%) χ2 P value 
Sex     
Male 220 37(16.8) 1.613 0.446 
Female 205 27(13.2)   
Age group     
0 – 14 24 4(16.7) 2.003 0.919 
15 – 34 159 27(17.0)   
35 – 54 163 24(14.7)   
≥ 55 79 9(11.4)   
HIV Status     
HIV Positive 159 29(18.2) 5.171 0.270 
HIV Negative 243 35(14.3)   
Unknown 21 0(0.0)   
Consumption of 
Nono 
    
Yes 128 23(18.0) 1.831 0.400 
No  297 41 (13.8)   
Location     
Urban 341 44(12.9) 8.104 0.017 
Rural 84 20(23.8)   
Ethnicity     
Tiv 267 25(9.4) 29.758 0.000 
Idoma 119 33(27.7)   
others 39 6(15.4)   
Hospital      
FMC 334 28(8.4) 120.3 0.000 
GHOTKP 59 29(49.2)   
GHNB 15 0(0.0)   
St. VH 17 7(41.2)   
Total  425 64(15.1)   
 
Prevalence of rifampicin resistance TB in Benue 
State: The overall prevalence of rifampicin 
resistance TB in this study was 3.1%. Patients from 
rural areas had significantly (χ2 = 10.625, P = 0.005) 
higher rate of rifampicin resistance than those from 
urban areas (8.3% vs 1.8%). Rifampicin resistance 
was highest among the Idoma ethnic group, 
5(4.2%), Tiv while the other ethnic groups had 2.6% 
respectively. The difference in the prevalence of 
rifampicin resistance among the different ethnic 
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groups was statistically significant (χ2 = 17.923, P = 
0.001). Prevalence of rifampicin resistance TB was 
most detected at St. Vincent Hospital, Aliade, i.e. 
2(11.8%), followed by General Hospital, Otukpo, 
3(5.1%). The difference in the detection of 
rifampicin resistance TB was significantly (χ2 = 
79.273, P = 0.000) different among the hospitals 
(Table 4). 
 
Table 4: Prevalence of rifampicin resistance TB in Benue State 
 
Variables No. Sampled RIF 𝜒2 P value 
Sex     
Male 220 8(3.6) 0.697 0.706 
Female 205 5(2.4)   
Age group     
0 – 14 24 0(0.0) 3.741 0.712 
15 – 34 159 7(4.4)   
35 – 54 163 3(1.8)   
≥ 55 79 3(3.8)   
HIV Status     
HIV Positive 159 5(3.1) 1.549 0.818 
HIV Negative 243 8 (3.3)   
Unknown 21 0(0.0)   
Consumption of 
Nono 
    
Yes 297 3(2.3) 1.750 0.417 
No 128 10(3.4)   
Location     
Urban 341 6(1.8) 10.623 0.005 
Rural 84 7(8.3)   
Ethnicity     
Tiv 267 7(2.6) 17.923 0.001 
Idoma 119 5(4.2)   
others 39 1(2.6)   
Hospital      
FMC 334 8(2.4) 79.273 0.000 
GHOTKP 59 3(5.1)   
GHNB 15 0(0.0)   
St. VH 17 2(11.8)   




Epidemiologic investigation was conducted among 
425 suspected TB patients of which 51.8% were 
males, 37.4% had HIV infection, 69.9% did not 
consume “nono” and 80.2% lived in urban areas. 
The overall prevalence of TB in this study was 
16.0% by acid-fast microscopy and 15.1% by 
GeneXpert MTB/RIF assay. It was also observed 
that the prevalence of TB by culture on LJ media 
was about twice (29.7%) the results obtained for 
acid-fast microscopy and GeneXpert assay. The 
high prevalence of TB by culture in this study may 
be because of the high isolation (66.67%) of NTM 
which cannot be detected by GeneXpert. Also, acid-
fast microcopy has low specificity compared with 
culture (26–28). 
The study observed that the prevalence of TB 
based on acid-fast microscopy, and GeneXpert did 
not vary significantly between males and females. 
Also, the prevalence of rifampicin resistance TB 
was not different among sexes. This observation was 
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consistent with previous studies in Nigeria (9,29). 
The reason for the lack of difference in the 
prevalence of TB between males and females in this 
study may be because both sexes are equally 
exposed to the pathogen in the study areas. 
However, results from culture indicated that males 
had significantly (χ2 = 3.879, P = 0.0497) higher 
prevalence of TB than females. 
Although results from GeneXpert and culture 
showed that the prevalence of TB was not 
statistically different among age groups, however, 
acid fast microscopy indicated that the prevalence of 
TB varies significantly ((χ2 = 8.468; p = 0.037) 
among age groups. Those in the age group of 15-34 
and 35-54 years old were the most affected. These 
groups represent active age group in the study areas. 
Since Benue State is an agrarian community that 
depends largely on manpower, agricultural output 
would be adversely affected and thus impacts 
negatively on the economy and living standard of 
the people. 
Evidently, there was no statistically significant 
difference in the prevalence of TB between those 
who consumed nono and those that did not. This 
may be due to increased awareness campaign on the 
public health important of hygienic practice and 
pasteurization of milk among pastoralist and local 
milk vendors in Nigeria (2). 
In this study, the prevalence of TB was 
statistically significant (P <0.05) among patients 
from rural areas than those from urban center as 
identified by acid-fast microscopy and GeneXpert 
assay. Also, the prevalence of rifampicin resistant 
TB was higher among TB patients from rural areas. 
The reason for the differences may be due to 
variation in access to quality healthcare; there are 
more health facilities in urban areas than in rural 
areas. Therefore, people in rural areas do not have 
adequate healthcare facilities. Most of the times, 
people from rural areas had to travel a long distance 
on bad road network to DOTs center, which may 
contribute to failure to adhere to treatment regime. 
Furthermore, non-availability of diagnostic facilities 
to accurately and timely diagnose TB and rifampicin 
resistant TB among rural dwellers may also 
contribute to the maintenance of the disease in rural 
areas (28,30). 
In this study, the isolation rate of NTM was 
higher than MTBC (84(66.67%) vs 42(33.33%)) 
from suspected TB patients. This finding was 
consistent with Bonnet et al,. (31), who 
demonstrated that two factors were associated with 
isolation of NTM, history of TB and HIV infection. 
Also, the growing incidence of tuberculosis-like 
illness caused by NTM may be one of the reasons 
for the high rate of NTM in this study.  In 
conclusion, the prevalence of TB and rifampicin 
resistance was highest in rural areas and the active 
age group. If this trend is left unchecked, it will have 
significant negative effect on the economy and 
living standard of the people. Also, it may have 
secondary negative effect on food security since 




We are most grateful to the technical staff of the 
Department of Microbiology and Research Unit, 
Federal Medical Centre, Makurdi, and General 
Hospital, Otukpo, for their kind support during the 




1.  WHO. Treatment of tuberculosis: guidelines. 
WHO. 2010.  
2.  WHO. Global Tuberculosis Report 2018. World 
Health Organization. Geneva; 2018.  
3.  Otu AA. A review of the national tuberculosis 
and leprosy control programme (ntblcp) of 
Nigeria: Challenges and prospects. Ann Trop 
Med Public Heal. 2013;6:491–500.  
4.  World Health Organization. Global tuberculosis 
report 2016. WHO Library Cataloguing-in-
Publication Data. 2016.  
5.  Ejeh EF, Okon KO, Kazeem HM, Undiandeye A, 
Akinseye VO, Cadmus SIB, et al. Diagnostic 
performance of GeneXpert and Ziehl-Neelson 
microscopy in the detection of tuberculosis in 
Benue State, Nigeria. Alexandria J Med. 2018; 
54:529–533.  
6.  Daniel O, Ogunfowora O, Oladapo O. HIV and 
tuberculosis co-infection in children; presentation 
Outcome, and treatment. Nig J Paediatr. 
2005;32(1):83–7.  
7.  Newton S, Brent A, Anderson S, Whittaker E, 
Kampmann B. Paediatric tuberculosis. Lancet 
Infect Dis. 2008; 8(8):498–510.  
8.  Anígilájé EA, Aderibigbe SA, Adeoti AO, 
              
             Isolation and Immunological Detection…                                                   Ejeh E. F  et al.                      
 
 
DOI:  http://dx.doi.org/10.4314/ejhs.v30i1.8 
 
63
Nweke NO. Tuberculosis, before and after 
antiretroviral therapy among HIV-infected 
children in Nigeria: What are the risk factors? 
PLoS One. 2016;1–19.  
9.  Iliyasu Z, Babashani M. Prevalence and 
Predictors of Tuberculosis Coinfection among 
HIV-Seropositive Patients Attending the Aminu 
Kano Teaching Hospital, Northern Nigeria. J 
Epidemiol. 2009;19(2):81–8.  
10.Ojiezeh TI, Ogundipe OO, Adefosoye VA. A 
retrospective study on incidence of pulmonary 
tuberculosis and human immunodeficiency virus 
co-infection among patients attending National 
Tuberculosis and Leprosy Control Programme, 
Owo centre. Pan Afr Med J. 2015; 20(345):1–5.  
11.Anteyi E, JA, Idoko, Ukoli C, Bello C. Clinical 
pattern of human immunodeficiency virus 
infection (HIV) in pulmonary tuberculosis 
patients in Jos, Nigeria. Afr J Med Med Sci. 1996; 
25(4):317–21.  
12.Onipede A, Idigbe O,  Ako-Nai AK, Omojola O, 
Oyelese AO, Aboderin AO, et al. Sero-
prevalence of HIV antibodies in tuberculosis 
patients in Ile-Ife, Nigeria. East Afr Med J. 1999; 
76(3):127–32.  
13.  TS, Imam OT. Retrospective study of 
pulmonary tuberculosis (PTB) prevalence among 
patients attending in infectious disease hospital. 
Bayero J Pure Appl Sci. 2008; 1(1):10–5.  
14.  Moses A, Adelowo K, Ajayi B. Prevalence of 
HIV-1 infection among patients with leprosy and 
pulmonary tuberculosis in a semi-arid region, 
Nigeria. J R Soc Heal. 2003;123(2):117–9.  
15.Nwadioha SI, Nwokedi EOP, Ezema GC, 
Eronini NC, Anikwe A, Audu F, et al. Drug 
Resistant Mycobacterium tuberculosis in Benue, 
Nigeria. Br Microbiol Res J  2014; 4(9):988–95.  
16.Ige O, Sogaolu O, OA Ogunlade. Pattern of 
presentation of tuberculosis and the hospital 
prevalence of tuberculosis and HIVco-infection 
in University College Hospital, Ibadan: a review 
of five years (1998–2002). Afr J Med Med Sci. 
2005; 34(4):329–33.  
17.Audu O, AgelaIgbabul S, Anejo-Okopi J, Joshua 
IA, Anefu GO, Isa S. Late Commencement of 
Anti-Tuberculosis Drugs in Three Directly 
Observed Treatment Short Course Centres in 
Benue State Nigeria: A Neglected Correlate of 
Tuberculosis Management. J Tuberc Res. 2017; 
5:05–105.  
18.Vange O, Umeh E, Azua E. The prevalence of 
tuberculosis and rifampicin resistance among the 
Mycobacterium tuberculosis clinical isolates at 
Federal Medical Centre Makurdi, Benue State, 
Nigeria. African J Microbiol Res. 2009AD; 
13(11):214–8.  
19.National Population Commission. The Federal 
Republic of Nigeria, 2006 Population and 
Housing Census. Population distribution by age 
and sex, priority table volume IV. National 
Population Commission. 2010.  
20.Mostowy S, Inwald J, Gordon S, Martin C, 
Warren R, Kremer K, et al. Revisiting the 
evolution of Mycobacterium bovis. J Bacteriol. 
2005;187:6386–95.  
21.Brosch R, Gordon S V., Marmiesse M, Brodin P, 
Buchrieser C, Eiglmeier K, et al. A new 
evolutionary scenario for the Mycobacterium 
tuberculosis complex. Proc Natl Acad Sci. 2002; 
99:3684–9.  
22.Arora J, Kumar G, Verma AK, Bhalla M, Sarin 
R, Myneedu VP. Utility of MPT64 Antigen 
Detection for Rapid Confirmation of 
Mycobacterium tuberculosis Complex. J Glob 
Infect Dis. 2015;  
23.  Kumar M, Handique F. Utility of a lateral flow 
assay for culture confirmation of Mycobacterium 
tuberculosis complex. Med J Armed Forces 
India. 2016;72(1):41–4.  
24.Kumar VG, Urs TA, Ranganath RR. MPT 64 
Antigen detection for Rapid confirmation of 
M.tuberculosis isolates. BMC Res Notes. 
2011;4(79):1–4.  
25.Bekmurzayeva A, Sypabekova M, Kanayeva D. 
Tuberculosis diagnosis using immunodominant, 
secreted antigens of Mycobacterium tuberculosis. 
Tuberculosis. 2013;93(4):381–8.  
26.Zeka AN, Tasbakan S, Cavusoglu C. Evaluation 
of the GeneXpert MTB/RIF assay for rapid 
diagnosis of tuberculosis and detection of 
rifampin resistance in pulmonary and 
extrapulmonary specimens. J Clin Microbiol. 
2011;49:4138–4141.  
27.Pinyopornpanish K, Chaiwarith R, Pantip C, 
Keawvichit R, Wongworapat K, Khamnoi P, et 
al. Comparison of Xpert MTB/RIF Assay and the 
           Ethiop J Health Sci.                               Vol. 30,  No. 1                                    January 2020 
 
 




Conventional Sputum Microscopy in Detecting 
Mycobacterium tuberculosis in Northern 
Thailand. Tuberc Res Treat. 2015;20(15):1–6.  
28.Ejeh EF, Okon KO, Kazeem HM, Undiandeye A, 
Akinseye VO, Cadmus SIB, et al. Diagnostic 
performance of GeneXpert and Ziehl-Neelson 
microscopy in the detection of tuberculosis in 
Benue State, Nigeria. Alexandria J Med. 2018; 
54:529–33.  
29.Daniel O, Osman E. Prevalence and risk factors 
associated with drug resistant TB in South West, 
Nigeria. Asian Pac J Trop Med. 2011; 2011:148–
51.  
30.WHO. Global Tuberculosis Report 2015. Global 
Tuberculosis Report 2015. 2015.  
31.Bonnet M, Chamroeun San K, Pho Y, Sok C, 
Dousset JP, Brant W, et al. Nontuberculous 
mycobacteria infections at a provincial reference 
hospital, Cambodia. Emerg Infect Dis. 2017; 
372(12):1181–2.  
 
 
 
 
  
